The 30 samples per day method
The longest standard method
The 30 SPD method is the longest of our standard methods with a 44-minute gradient.
It is a popular choice for routine applications such as measuring proteome and post-translational modified peptides.
HIGHEST PROTEOME COVERAGE
This method provides the highest proteome coverage among our standard methods with close to 25,000 unique peptides identified in data-dependent acquisition mode.
The five standard methods
With the five standard methods, the Evosep One covers a range of use cases from comprehensive proteome analysis with fractionation strategies to ultra high-throughput single-shot analysis. You device how fast you want to go.
The highest peak capacity per minute with our fastest method for ultra-high throughput analysis.
Excellent sequencing speed with most peptides per minute among our standard methods.
A great “in-between” method with run-to-run reproducibility of just one second.
Do you want to know how our users are already taking advantage of the 30 Samples per day method? Find all publications from users and collaboration partners here. Visit our Literature Room for a full overview.
|Title||Subject||Material||Year||Summary||Institute||Evosep method||MS instrumentation||Learn More|
|Towards a Standardized Omics Platform with the 30 samples per day method||Technology||Application note||2019||This is the longest of our standard methods with a 44-minute gradient and a cycle time of 48 minutes.||30 SPD|
|The proteomics dilemma – High throughput analysis versus proteome depth||Technology||Application note||2019||With the five standard methods, the Evosep One covers a range of use cases from comprehensive proteome analysis with fractionation strategies to ultra high-throughput single-shot analysis.||100 SPD, 200 SPD, 30 SPD, 300 SPD, 60 SPD|
|Co-translational assembly and localized translation of nucleoporins in nuclear pore complex biogenesis||DDA, Protein interaction||Publication||2021||In this study, the Palancade group provides the complete depiction of the co-translational events involved in the biogenesis of a large multiprotein assembly, the nuclear pore complex (NPC) in yeast. Their data reveal that distinct, spatially segregated modes of co-translational interactions foster the ordered assembly of NPC subunits.||30 SPD|
|Hemorrhage and saline resuscitation are associated with epigenetic and proteomic reprogramming in the rat lung||DDA, Lung, Tissue||Publication||2021||In this study, the Sillesen group investigates the alteration of the proteome in the context of hemorrhage and saline resuscitation in trauma patients. They used rat lungs as a model and pooled 10 rats in one combined TMT experiment subjected to high pH offline fractionation.||30 SPD||Thermo Orbitrap Fusion|
|Malaria Parasite Schizont Egress Antigen-1 Plays an Essential Role in Nuclear Segregation during Schizogony||DDA, Malaria, Protein interaction||Publication||2021||This publication by the Blackman group describes the role of SEA1, a suggested malaria vaccine antigen candidate. They conclude that SEA1 does not play a direct mechanistic role in egress to invade new erythrocytes but instead is an essential blood-stage protein that plays an important role in orchestrating the correct partitioning of DNA into merozoites.||30 SPD||Thermo Orbitrap Fusion Lumos|
|The COVIDome Explorer Researcher Portal||Clinical research, Covid-19, DDA, Plasma||Publication||2021||Researchers from University of Colorado led by Joaquin M. Espinosa, have created a user-friendly researcher portal enabling easy access and real-time analysis of matched multi-omics datasets for COVID-19, termed the COVIDome Explorer. They illustrate the use through a multi-omics analysis of biosignatures associated with C-reactive protein (CRP), an established marker of poor prognosis in COVID-19.||30 SPD||Bruker timsTOF Pro|
|The Host Interactome of Spike Expands the Tropism of SARS-CoV-2||Clinical research, Covid-19, Protein interaction||Publication||2021||This publication from the Yates lab, investigates the host interactome determining whether a SARS-CoV-2 infection is productive. They find an “S2 only” dependent, alternative infection of additional cell types with SARS-CoV-2 may impact vaccination strategies and provide a molecular explanation for a severe or prolonged progression of disease in select COVID-19 patients.||30 SPD||Bruker timsTOF Pro|
|Basement membrane stiffness determines metastases formation||DDA, Lung, Tissue, TMT||Publication||2021||In this study, the Erler group from the BRIC Institute at University of Copenhagen, Denmark identifies Net4 as a key regulator of basement membrane stiffness, a special type of extracellular matrix, which presents the major barrier cancer cells have to overcome multiple times to form metastases.||30 SPD||Thermo Orbitrap Exploris 480|
|Interactions of Viral Proteins from Pathogenic and Low or Non-Pathogenic Orthohantaviruses with Human Type I Interferon Signaling||DDA, Protein interaction||Publication||2021||A collaboration led by the Ermonval group from Institute Pasteur describes the interactions of structural and non-structural proteins of pathogenic and low or non-pathogenic orthohantaviruses with human type I Interferon signaling. They suggest that the activation of IFN-I is probably not the only antiviral pathway to be counteracted by orthohantaviruses.||30 SPD||Thermo Orbitrap Fusion|
|Seroconversion stages COVID19 into distinct pathophysiological states||Clinical research, Covid-19, Plasma||Publication||2020||In this study, researchers from University of Colorado led by Joaquin M. Espinosa, found highly variable seroconversion status among hospitalized Covid-19 patients. Their results support the existence of distinct pathophysiological states, with seroconversion status being potentially useful as a surrogate marker of underlying processes.||30 SPD||Bruker timsTOF Pro|
|Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites||Clinical research, Parkinson's disease, Targeted workflow||Publication||2020||This publication from University of Dundee led by Dario R Alessi, describes the validation and development of a new, multiplexed targeted assay that enables the relative quantification of the key components of the LRRK2 pathway, defining the impact of LRRK2 inhibitors and Parkinson’s disease causing mutations.||30 SPD, 60 SPD||Thermo Orbitrap Exploris 480|
|High dynamic range proteome analysis with BoxCar DIA and super-resolution Orbitrap mass spectrometry||DIA, Plasma, Technology||Poster||2020||BoxCar DIA||100 SPD, 30 SPD||Thermo Orbitrap Exploris 480|
|Evosep One Enables Robust Deep Proteome Coverage Using Tandem Mass Tags While Significantly Reducing Instrument Time||DDA, Lung, Tissue, TMT||Video||2019||Comparison study with TMT, same coverage in shorter time||30 SPD, 60 SPD||Thermo Orbitrap Fusion Lumos|
|Sensitive, Rapid, Robust and Reproducible Workflow for Host Cell Protein Profiling in Biopharmaceutical Process Development||Biopharma, DDA, HCP||Publication||2020||HCP analysis in Biopharma||30 SPD, 60 SPD||Thermo Orbitrap Fusion Lumos|
|Characterization of glutathione proteome in CHO cells and its relationship with productivity and cholesterol synthesis||DDA, TMT||Publication||2020||30 SPD||Thermo Q Exactive HF-X|
|An Ultra High-Throughput Plasma Protein Profiling (uHTPPP) Workflow Using a Modified Quadrupole-Orbitrap Mass Spectrometer||Clinical research, DDA, Lung, Plasma, Serum, Tissue||Application note||2020||In this application note, the group of Emily Chen at the Thermo Fisher Precision Medicine Science Center describes a high-throughput plasma and serum proteomics analysis workflow for large population cohort studies that utilizes a standardized sample preparation method, high-throughput data acquisition, and easy to implement QC standard.||30 SPD, 60 SPD||Thermo Orbitrap Exploris 240|
|Scalable and Automated Plasma Workflow Based on the Thermo Scientific Q Exactive HF-X MS Platform||Clinical research, DDA, Lung, Plasma, Serum||Application note||2019||In this application note, the group of Emily Chen at PMSC describes a high-throughput plasma and serum proteomics analysis workflow for large population cohort studies that utilizes a standardized sample preparation method, high-throughput data acquisition, and easy to implement QC standard.||100 SPD, 30 SPD, 60 SPD||Thermo Q Exactive HF-X|
|Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV||Clinical research, Covid-19, DIA, PTM||Publication||2020||This publication describes the molecular functions of viral proteins and their interactions with the host proteome of SARS-CoV-2. The impact of viral infection on the proteome and phosphoproteome were analyzed in a time-resolved manner by DIA. The analysis revealed key pathways perturbed during the infection identifying potential vulnerable points of SARS-CoV-2.||30 SPD, 60 SPD||Thermo Q Exactive HF-X|
|A paired liver biopsy and plasma proteomics study reveals circulating biomarkers for alcohol-related liver disease||Clinical research, DIA, Liver, Plasma||Publication||2020||This publication from Matthias Mann groups in Copenhagen and Münich describes a paired liver biopsy and plasma proteomics study, which make use of Boxcar DIA scanning for a large clinical cohort of nearly 600 patients. They have developed a machine learning model based on their biomarker panel, which for the first time outperforms existing tests, …||30 SPD||Thermo Q Exactive HF-X|
|Evosep One Enables Robust Deep Proteome Coverage Using Tandem Mass Tags While Significantly Reducing Instrument Time||Offline fractionation, Tissue, TMT||Video||2019||Comparison study with TMT, same coverage in shorter time||30 SPD, 60 SPD||Thermo Orbitrap Fusion Lumos|
|Covalent Protein Painting Reveals Structural Changes In The Proteome In Alzheimer Disease||Alzheimer Disease, Brain, DDA, Tissue||Publication||2020||Development of Covalent Protein Painting (CPP), a structural proteomics approach to quantify changes in protein fold or altered protein-protein interaction for any protein in a proteome. CPP directly determines the relative surface accessibility of amino acid side chains by measuring the molar fraction of a chemical functionality that is accessible for chemical modification on the …||30 SPD||Thermo Orbitrap Fusion Lumos|
We’d love to hear from you!
Need more information, do not hesitate to contact us.